GenDx Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 82

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 3

GenDx General Information

Description

Provider of molecular diagnostics tools intended for solid organ and stem cell transplantation. The company develops and offers a comprehensive line of reagents and services, analysis software and education for human leukocyte antigen (HLA) typing, thereby enabling healthcare providers and organizations to get crucial information for patient-tailored treatments.

Contact Information

Website
www.gendx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Medical Supplies
Other Industries
Other Healthcare Technology Systems
Parent Company
Corporate Office
  • Yalelaan 48
  • 3584 CM Utrecht
  • Netherlands
+31 030 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenDx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GenDx‘s full profile, request access.

Request a free trial

GenDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of molecular diagnostics tools intended for solid organ and stem cell transplantation. The company develops and
Medical Supplies
Utrecht, Netherlands
82 As of 2022
00000 0000-00-00
000000&0

000000

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullam
0000000000 000000000
Mechelen, Belgium
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GenDx Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocartis Formerly VC-backed Mechelen, Belgium 000 00000 000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

GenDx Executive Team (9)

Name Title Board Seat Contact Info
Maarten Penning Ph.D Chief Technology Officer
Roelien Brommersma Chief Human Resources Officer
Boudewijn Erasmus Director, Contract Management
Erik Rozemuller Ph.D Co-Founder & Senior Scientist Bioinformatics
Andreas Kuhröber Ph.D Chief Commercial Officer
You’re viewing 5 of 9 executive team members. Get the full list »

GenDx Board Members (7)

Name Representing Role Since
000 00000 00.0 GenDx Board Member 000 0000
00000 0000000 00.0 GenDx Co-Founder and Board Member 000 0000
00000 0000000000 Self Co-Founder & Chairman 000 0000
You’re viewing 3 of 7 board members. Get the full list »

GenDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenDx Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GenDx‘s full profile, request access.

Request a free trial

GenDx Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Scope Biosciences 29-Oct-2021 000000000 00.000 Biotechnology 000000 00
Kimerdx 01-Jan-2018 0000000000 Diagnostic Equipment 000000 00
Kimerdx 31-Oct-2013 Joint Venture Diagnostic Equipment 0000 0000
To view GenDx’s complete investments and acquisitions history, request access »

GenDx FAQs

  • When was GenDx founded?

    GenDx was founded in 2005.

  • Who is the founder of GenDx?

    Erik Rozemuller Ph.D, Oscar Schoots Ph.D, Wietse Mulder Ph.D, and Raoul Linschoten are the founders of GenDx.

  • Where is GenDx headquartered?

    GenDx is headquartered in Utrecht, Netherlands.

  • What is the size of GenDx?

    GenDx has 82 total employees.

  • What industry is GenDx in?

    GenDx’s primary industry is Medical Supplies.

  • Is GenDx a private or public company?

    GenDx is a Private company.

  • What is the current valuation of GenDx?

    The current valuation of GenDx is 00000.

  • What is GenDx’s current revenue?

    The current revenue for GenDx is 00000.

  • Who are GenDx’s investors?

    Ampersand Capital Partners and Utrecht Holdings have invested in GenDx.

  • Who are GenDx’s competitors?

    Biocartis is a competitor of GenDx.

  • When was GenDx acquired?

    GenDx was acquired on 17-Aug-2022.

  • Who acquired GenDx?

    GenDx was acquired by Eurobio Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »